Featured patents

Adjuvant Incorporation in Immunonanotherapeutics
US 08637028 B2, Jan. 28, 2014, Matteo Iannacone et al. / President and Fellows of Harvard College (Cambridge, US)
A composition comprising:…

Alpha-4 Beta-7 Heterodimer Specific Antagonist Antibody
US 08444981 B2, May 21, 2013, Frederick W. Jacobsen et al. / Amgen Inc. (Thousand Oaks, US)
An isolated, alpha4beta7 heterodimer specific antigen binding protein having…

Alpha-4-Beta-7 Heterodimer Specific Antagonist Antibody
US 08454962 B2, June 4, 2013, Frederick W. Jacobsen et al. / Amgen Inc. (Thousand Oaks, US)
An isolated, alpha4beta7 heterodimer specific antigen binding protein having…

Alpha-4-Beta-7 Heterodimer Specific Antagonist Antibody
US 08454961 B2, June 4, 2013, Taruna Arora et al. / Amgen Inc. (Thousand Oaks, US)
An isolated, alpha4beta7 heterodimer specific antigen binding protein having…

Antagonists of IL-23P19 for Treatement of Atopic Dermatitis
US 08795666 B2, Aug. 5, 2014, Kevin Moore et al. / Merck Sharp & Dohme Corp. (Rahway, US)
A method of treating a human subject experiencing atopic dermatitis comprising…

Anti-EGFR Family Antibodies, Bispecific Anti-EGFR Family Antibodies and Methods of Use Thereof
US 08580263 B2, Nov. 12, 2013, Gregory P. Adams et al. / The Regents of the University of California (Oakland, US)
An isolated antibody that binds to an EGFR family member, wherein said antibody…

Anti-ERBB2 Antibody Adjuvant Therapy
US 08591897 B2, Nov. 26, 2013, John L. Bryant / Genentech, Inc. (South San Francisco, US)
A method of adjuvant therapy comprising administering to a human subject…

Anti-GITR Antibodies
US 08709424 B2, April 29, 2014, Xiao Min Schebye et al. / Merck Sharp & Dohme Corp. (Rahway, US)
A binding compound that binds to human GITR comprising:…

Anti-Human Epidermal Growth Factor Receptor Antibody and Uses Thereof
US 08758756 B2, June 24, 2014, Jyuan-Jyuan Syu et al. / Industrial Technology Research Institute (Hsinchu, TW)
An anti-human epidermal growth factor receptor (EGFR) antibody, comprising…

Anti-IGF-IR Antibodies and Uses Thereof
US 08444982 B2, May 21, 2013, Mei-Yun Zhang / The University of Hong Kong (Hong Kong, CN)
An isolated polypeptide comprising an antibody or a binding fragment…

Anti-IL-6 Receptor Antibodies and Methods of Use
US 08753634 B2, June 17, 2014, Sum Wai Pierre Lee et al. / Apexigen, Inc. (Burlingame, US)
An isolated antibody, or an antigen-binding fragment thereof, that binds…

Anti-VEGFR-3 Antibody Compositions
US 08481034 B2, July 9, 2013, Nathalie Zayek et al. / ImClone, LLC (Indianapolis, US)
An antibody or fragment thereof that binds to human VEGFR-3 comprising a LCDR1…

Antibodies Directed to HER-3 and Uses Thereof
US 08771695 B2, July 8, 2014, Robert Radinsky et al. / U3 Pharma GmbH DE
A method for treating a HER-3 expressing cancer in a patient, comprising…

Antibodies That Specifically Bind to the EphA2 Receptor
US 08668910 B2, March 11, 2014, Ingrid Sassoon et al. / Sanofi (Paris, FR)
An antibody or an epitope-binding fragment thereof that specifically binds…

Antibodies to Insulin-Like Growth Factor I Receptor
US 08642037 B2, Feb. 4, 2014, Jean Beebe et al. / Amgen Fremont Inc. (Thousand Oaks, US)
A monoclonal antibody or an antigen-binding portion thereof that binds…

Antibodies to Non-Functional P2X 7 Receptor
US 08709425 B2, April 29, 2014, Angus Gidley-Baird et al. / Biosceptre International Limited AU
An isolated antibody that binds to an extracellular domain of a P2X7 receptor,…

Antibody Molecules That Bind to IL-6 Receptor
US 08562991 B2, Oct. 22, 2013, Tomoyuki Igawa et al. / Chugai Seiyaku Kabushiki Kaisha (Tokyo, JP)
An isolated anti-IL-6 receptor antibody that comprises a heavy chain variable…

Antibody Selective for a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor DR5 and Uses Thereof
US 08715668 B2, May 6, 2014, William J. Koopman et al. / The UAB Research Foundation (Birmingham, US)
A purified antibody that binds DR5 comprising a heavy chain and a light chain…

Cancer Treatment With Endothelin Receptor Antagonists
US 08597645 B2, Dec. 3, 2013, Robert Schneider et al. / New York University (New York, US)
A method for inhibiting the early development of mammary cancer in a patient…

Chimeric Antigens for Eliciting an Immune Response
US 08465745 B2, June 18, 2013, Allan Ma et al. / Akshaya Bio Inc. CA
A purified chimeric antigen for eliciting an immune response against Hepatitis C…

Composition Comprising Antibody That Binds to Domain II of HER2 and Acidic Variants Thereof
US 08652474 B2, Feb. 18, 2014, Reed J. Harris et al. / Genentech, Inc. (South San Francisco, US)
A composition comprising a main species HER2 antibody that binds to domain II…

Composition of a First Non-Labeled Monoclonal Antibody Binding to a Tumor Antigen and a Non-Cross Reactive Second Monoclonal Antibody Labeled With a NIR Fluorescence Label
US 08529901 B2, Sept. 10, 2013, Max Hasmann et al. / Hoffmann-La Roche, Inc. (Nutley, US)
A method for NIR fluorescence imaging of solid tumors during treatment…

Composition of Anti-ENDO180 Antibodies and Methods of Use for the Treatment of Cancer and Fibrotic Diseases
US 08444983 B2, May 21, 2013, Elena Feinstein / Quark Pharmaceuticals, Inc. (Fremont, US)
An anti-ENDO180 antibody or an antigen-binding fragment selected from the group…

Compositions and Methods for Increasing Muscle Growth
US 08551482 B2, Oct. 8, 2013, Catrin Berger et al. / Novartis AG (Basel, CH)
An isolated antibody or functional fragment thereof capable of binding to each…

EGFR-binding Molecules and Immunoconjugates Thereof
US 08790649 B2, July 29, 2014, Thomas Chittenden et al. / ImmunoGen, Inc. (Waltham, US)
An isolated antibody or antigen binding fragment thereof that specifically binds…

EPHA2 Receptor Antagonist Antibodies
US 08460667 B2, June 11, 2013, Min Li et al. / Sanofi (Paris, FR)
An isolated antibody or an epitope-binding fragment thereof that specifically…

Function Modifying NAv 1.7 Antibodies
US 08734798 B2, May 27, 2014, Karen Margrete Miller et al. / UCB Pharma S.A. (Brussels, BE)
An anti-Na v 1.7 antibody or binding fragment thereof which, after…

Human Monoclonal Antibodies to the Thyrotropin Receptor Which Act as Antagonists
US 08840891 B2, Sept. 23, 2014, Jane Sanders et al. / RSR Limited (Cardiff, GB)
An isolated human monoclonal or recombinant antibody for the Thyroid Stimulating…

Humanized Anti-HLA-DR Antibodies
US 08722047 B2, May 13, 2014, Hans J. Hansen et al. / Immunomedics, Inc. (Morris Plains, US)
A humanized anti-HLA-DR antibody or antigen-binding fragment thereof…

Interferon Alpha Receptor I Antibodies and Their Use
US 08460668 B2, June 11, 2013, Alison Witte et al. / Medarex, Inc. (Princeton, US)
A method of treating systemic lupus erythematosus in a subject in need…

Patentorg has 49 documents under Binds Receptor Patents.

Other subcategories for category Drug, bio-affecting and body treating compositions
Quick navigation
New documents
  • Process for the Production of the Actinobacillus Pleuropneumoniae Toxins APXI or APXIII in a Liquid Culture Medium Under Supply of Air Enriched in Carbon Dioxide
  • Method for Manufacturing Nonvolatile Memory Device
  • Supply Chain Demand Satisfaction
  • Supply-Line Management Device
  • Storage Control Device and Method for Managing Snapshot